FDA NDC Directory · JSON-LD · Markdown

Varubi

NDC 70720-101 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namerolapitant
Labeler / ManufacturerTerSera Therapeutics LLC
Marketing categoryNew Drug Application (innovator) · App NDA206500
Dosage form / routeTABLET · ORAL
Active ingredientsROLAPITANT HYDROCHLORIDE (90 mg/1)
Marketing started20151007
Package count1

External sources

Source: openFDA. Public-domain (CC0).